↓ Skip to main content

Dove Medical Press

Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
63 Mendeley
Title
Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review
Published in
Therapeutics and Clinical Risk Management, February 2020
DOI 10.2147/tcrm.s214187
Pubmed ID
Authors

Najwa Taghy, Linda Cambon, Jean-Marie Cohen, Claude Dussart

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 14%
Other 6 10%
Student > Master 6 10%
Researcher 4 6%
Student > Postgraduate 3 5%
Other 11 17%
Unknown 24 38%
Readers by discipline Count As %
Medicine and Dentistry 15 24%
Pharmacology, Toxicology and Pharmaceutical Science 11 17%
Nursing and Health Professions 6 10%
Social Sciences 2 3%
Agricultural and Biological Sciences 1 2%
Other 3 5%
Unknown 25 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#8,540,769
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#462
of 1,323 outputs
Outputs of similar age
#176,033
of 470,256 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#7
of 14 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,256 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.